Esophageal Cancer Prevention–for health professionals (PDQ®)

SECTIONS

Changes to This Summary (12/10/2015)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Overview

Added text to state that other factors that may explain the increased risk of adenocarcinoma of the esophagus include obesity and the use of medications, such as anticholinergics that can predispose to gastroesophageal reflux disease by relaxing the lower esophageal sphincter (cited 2006 Lagergren et al. as reference 2 and 2000 Lagergren et al. as reference 3).

This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Description of the Evidence

Next section >
About This PDQ Summary